Sign Up to like & get
recommendations!
0
Published in 2021 at "Proceedings of the National Academy of Sciences of the United States of America"
DOI: 10.1073/pnas.2111703119
Abstract: Significance Myelodysplastic syndromes (MDS) are the most commonly diagnosed malignancy of the elderly in the United States, but what causes severe anemia in MDS has been unknown. Our findings provide a detailed mechanism underlying the…
read more here.
Keywords:
differentiation;
sf3b1 mutant;
mds patients;
map3k7 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-111552
Abstract: Mutations in genes encoding RNA splicing factors constitute the most common class of genetic alterations in patients with myelodysplastic syndromes (MDS). These occur as heterozygous point mutations at specific amino acid residues in SF3B1, SRSF2,…
read more here.
Keywords:
sf3b1;
map3k7;
figure;
sf3b1 mutant ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Blood"
DOI: 10.1182/blood-2020-140817
Abstract: Splicing is a fundamental process by which introns are removed from primary RNA transcripts. Alternative splicing is a major mechanism of gene regulation by which eukaryotic cells expand their transcriptional repertoire. By contrast, aberrant splicing…
read more here.
Keywords:
sf3b1;
formation;
sf3b1 mutant;
mutant sf3b1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Blood"
DOI: 10.1182/blood.2021010831
Abstract: Komrokji et al examined the proposed international working group proposal to designate SF3B1-mutant myelodysplastic syndrome (MDS) as a unique disease entity, using a single-institution validation cohort of 1779 MDS patients, of whom 320 harbored SF3B1…
read more here.
Keywords:
mutant myelodysplastic;
working group;
international working;
sf3b1 mutant ... See more keywords